Skip to main navigation Skip to search Skip to main content

Reconsidering Off-Label Pediatric COVID-19 Vaccination

Research output: Contribution to JournalComment/Essay/Note

Abstract

Off-label vaccination is not a widespread public health strategy. Structural responses are also necessary, like the American Academy of Pediatrics publishing its own vaccine schedule and filing a lawsuit against HHS challenging the legality of the Secretary’s decision to remove healthy children and pregnant people from the CDC immunization schedules. However, vaccinating children off-label is an ethically and legally supportable tool at a time when other tools are being removed from the toolkit. It is a decision between parents and trusted pediatricians that may also be involved for other vaccines as the regulatory and public health administrative landscape evolves and until policy priorities from federal health care agency leaders return to evidence-based public health.

Original languageAmerican English
JournalJAMA Pediatrics
DOIs
StateE-pub ahead of print - Sep 29 2025

Cite this